|
Characteristics
|
Complete (n = 25)
|
Failure (n = 4)
|
P value
|
|---|
|
Age, years
|
64.9 ± 8.19
|
69.5 ± 2.69
|
0.182
|
|
Sex, male (n) [%]
|
21/25 (80.7)
|
2/4 (50.0)
|
0.180†
|
|
Duration of hemodialysis (years)
|
16.1 ± 9.5
|
15.3 ± 10.4
|
0.393*
|
|
Previous treatment (n) [%]
|
|
Naïve
|
19/25 (76.0)
|
1/4 (25.0)
|
0.076†
|
|
Relapse and non-viral response
|
6/25 (24.0)
|
3/4 (75.0)
| |
|
Liver cirrhosis (n) [%]
|
6/25 (24.0)
|
3/4 (75.0)
|
0.076†
|
|
Serum HCV-RNA levels (log10 IU/mL)
|
5.06 ± 0.99
|
5.88 ± 0.28
|
0.158*
|
|
≥5.0 log10 IU/mL (n) [%]
|
16/25 (64.0)
|
4/4 (100)
|
0.280†
|
|
≥5.5 log10 IU/mL (n) [%]
|
9/25 (36)
|
4/4 (100)
|
0.030†
|
|
NS5A inhibitor RAVs (n) [%]
|
2/25 (8)
|
0/4 (0)
|
1.000†
|
- Data are expressed as median, number (%), or mean ± standard deviation
- *Mann-Whitney U test, †Fisher’s exact test
